Selected papers

Rusz JHlavnicka JNovotny MTykalova T, Pelletier A, Montplaisir J, Gagnon J-F, Dusek P, Galbiati A, Marelli S, Timm PC, Teigen LN, Janzen A, Habibi M, Stefani A, Holzknecht E, Seppi K, Evangelista E, Rassu AL, Dauvilliers Y, Hogl B, Oertel W, St Louis EK, Ferini-Strambi L, Ruzicka E, Postuma RB, Sonka K. Speech biomarkers in rapid eye movement sleep behaviour disorder and Parkinson’s disease. Ann Neurol 2021; 90:62-75. [PDF]

J. HlavničkaT. Tykalová, O. Ulmanová, P. Dušek, D. Horáková, J. Klempíř, and J. Rusz. (2020). “Characterizing vocal tremor in progressive neurological diseases via automated acoustic analyses,” Clinical Neurophysiology, 131(5 May): 1155-1165. [PDF] [Editorial]

J. HlavničkaR. Čmejla, J. Klempíř, E. Růžička, and J. Rusz. (2019).”Acoustic tracking of pitch, modal and subharmonic vibrations of vocal folds in Parkinson’s disease and Parkinsonism,” IEEE Access7(December): 150339-150354. [PDF]

J. HlavničkaR. ČmejlaT. Tykalová, K. Šonka, E. Růžička, and J. Rusz (2017). “Automated analysis of connected speech reveals early biomarkers of Parkinson’s disease in patients with rapid eye movement sleep behaviour disorder,” Scientific Reports7(February): 12. [PDF] [cited]

J. RuszJ. HlavničkaT. Tykalová, J. Bušková, O. Ulmanová, E. Růžička and K. Šonka. (2016). “Quantitative assessment of motor speech abnormalities in idiopathic rapid eye movement sleep behaviour disorder,” Sleep Medicine19(3 March): 141-147. [PDF] [cited]

RuszJ. HlavničkaR. Čmejla, and E. Růžička. (2015). “Automatic evaluation of speech rhythm instability and acceleration in dysarthrias associated with basal ganglia dysfunction,” Frontiers in Bioengineering and Biotechnology3(July):104. [PDF] [cited]

All publications

2022

Subert MSimek MNovotny MTykalova T, Bezdicek O, Ruzicka E, Sonka K, Dusek P, Rusz J. Linguistic abnormalities in isolated rapid eye movement sleep behavior disorder. Mov Disord 2022; in press. [PDF]

Novotny MTykalova T, Ruzickova H, Ruzicka E, Dusek P, Rusz J. Automated video-based assessment of facial bradykinesia in de-novo Parkinson’s disease. NPJ Dig Med 2022;98. [PDF]

Svoboda E, Boril T, Rusz JTykalova T, Horakova D, Guttmann CRG, Blagoev KB, Hatabu H, Valtchinov VI. Assessing clinical utility of machine learning and artificial intelligence approaches to analyze speech recordings in multiple sclerosis: A pilot study. Comp Biol Med 2022;148:105853. [PDF]

Kouba TIllner VRusz J. Study protocol for using a smartphone application to investigate speech biomarkers of Parkinson’s disease and other synucleinopathies: SMARTSPEECH. BMJ Open 2022; 12:e059871. [PDF]

Holly P, Duspivova T, Kemlink D, Ulmanova O, Rusz J, Krupicka J, Jech R, Ruzicka E. Práh pro somatosenzorickou časovou diskriminaci nediferencuje mezi pacienty s esenciálním a dystonickým třesem hlavy. Cesk Slov Neurol N 2022;85/118:163-167. [PDF]

Viteckova S, Rusz J, Ruzicka E, Krupicka R. Is Gait Dysfunction Prominent Sign of Isolated Rapid Eye Movement Sleep Behavior Disorder? Mov Disord 2022;37:1575-1576. [PDF]

Ganapathy R, Levová K, Kotačková L, Trnka J, Zogala D, Rusz J, Zima T, Devos D, Šonka K, Růžička E, Kalousová M, Dušek. Increased transferrin sialylation predicts phenoconversion in isolated REM sleep behavior disorder. Mov Disord 202237:983-992. [PDF]

Illner VTykalova TNovotny M, Klempir J, Dusek P, Rusz J. Towards automated articulation rate analysis via connected speech in dysarthrias. J Speech Lang Hear Res; 2022;65:1386-1401. [PDF]

Tykalova TNovotny M, Ruzicka E, Dusek P, Rusz J. Short-term effect of dopaminergic medication on speech in early-stage Parkinson’s disease. NPJ Parkinsons Dis 2022; 8:22. [PDF]

Rusz J, Janzen A, Tykalova TNovotny M, Zogala D, Timmermann L, Růžička E, Šonka K, Dušek P, Oertel W. Dysprosody in Isolated REM Sleep Behavior Disorder with Impaired Olfaction but Intact Nigrostriatal Pathway. Mov Disord 2022; 37:619-623. [PDF]

Rusz JTykalova TNovotny M, Zogala D, Růžička E, Dušek P. Automated speech analysis in early untreated Parkinson’s disease: relation to gender and dopaminergic transporter imaging. Eur J Neurol 2022; 29:81-90. [PDF]

2021

Šimek MRusz J. Validation of cepstral peak prominence in assessing early voice changes of Parkinson’s disease: effect of speaking task and ambient noise. J Acoust Soc Am 2021; 150:4522-4533.

Rusz JTykalova T. Does Cognitive Impairment Influence Motor Speech Performance in De Novo Parkinson’s Disease? Mov Disord 2021; 36:2980-2982. [PDF]

Rusz JTykalova TNovotny M, Růžička E, Dušek P. Distinct patterns of speech disorder in early-onset and late-onset de-novo Parkinson’s disease. NPJ Parkinsons Dis 2021; 7:98. [PDF]

Rusz JTykalova TNovotny M, Zogala D, Šonka K, Růžička E, Dušek P. Defining speech subtypes in de novo Parkinson’s disease: response to long-term levodopa therapy. Neurology 2021; 97:e2124-e2135. [PDF]

T. TykalováD. Škrabal, T. Bořil, R. Čmejla, J. Volín, and J. Rusz. Effect of aging on acoustic characteristics of voice pitch and formants in Czech vowels,” Journal of Voice 2021; 931.e21-931.e33. [PDF]

Vasquez-Correa JC, Rios-Urrego CD, Arias-Vergara T, Schuster M, Rusz J, Nöth E, Orozco-Arroyave JR. Transfer Learning Helps to Improve the Accuracy to Classify Patients with Different Speech Disorders in Different Languages. Pattern Recognit Lett 2021; 150:272-279. [PDF]

Miglis MG, Adler CH, Antelmi E, Arnaldi D, Baldelli L, Boeve BF, Cesari M, Dall’Antonia I, Diederich NJ, Doppler K, Dušek P, Ferri R, Gagnon J-F, Gan-Or Z, Hermann W, Högl B, Hu MT, Iranzo A, Janzen A, Kuzkina A, Lee J-Y, Leenders KL, Lewis SJG, Liguori C, Liu J, Lo C, Ehgoetz Martens KA, Nepozitek J, Plazzi G, Provini F, Puligheddu M, Rolinski M, Rusz J, Stefani A, Summers RLS, Yoo D, Zitser J, Oertel WH. Biomarkers of conversion to alpha-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder. Lancet Neurol 2021;20:671-684. [PDF]

Rusz JHlavnicka JNovotny MTykalova T, Pelletier A, Montplaisir J, Gagnon J-F, Dusek P, Galbiati A, Marelli S, Timm PC, Teigen LN, Janzen A, Habibi M, Stefani A, Holzknecht E, Seppi K, Evangelista E, Rassu AL, Dauvilliers Y, Hogl B, Oertel W, St Louis EK, Ferini-Strambi L, Ruzicka E, Postuma RB, Sonka K. Speech biomarkers in rapid eye movement sleep behaviour disorder and Parkinson’s disease. Ann Neurol 2021; 90:62-75. [PDF]

Kryze PTykalova T, Ruzicka E, Rusz J. Effect of reading passage length on quantitative acoustic speech assessment in Czech-speaking individuals with Parkinson’s disease treated with subthalamic nucleus deep brain stimulation. J Acoust Soc Am 2021;3366-3374. [PDF]

Rusz JSvihlik JKryze PNovotny MTykalova T. Reproducibility of Voice Analysis with Machine Learning. Mov Disord 2021; 36:1282-1283. [PDF]

Rusz JTykalova T, Ramig LO, Tripoliti E. Reply to: “Fostering Voice Objective Analysis in Patients With Movement Disorders”. Mov Disord 2021; 36:1042-1043. [PDF]

Rusz JTykalova T, Ramig LO, Tripoliti E. Guidelines for speech recording and acoustic analyses in dysarthrias of movement disorders. Mov Disord 2021; 36:230-238. [PDF]

2020

Polakova K, Ruzicka E, Jech R, Kemlink D, Rusz J, Miletinova E, Brozova H. 3D visual cueing shortens the double support phase of the gait cycle in patients with advanced Parkinson’s disease treated with DBS of the STN. PLoS ONE 2020; 15(12): e0244676. [PDF]

M. NovotnyJ. MelechovskyK. RozenstoksT. TykalovaP. KryzeM. Kanok, J. Klempir, and J. Rusz. (2020). “Comparison of Automated Acoustic Methods for Oral Diadochokinesis Assessment in Amyotrophic Lateral Sclerosis,” Journal of Speech, Language and Hearing Research, 63 (10 November): 3453-3460. [PDF]

E. Eyigoz, M. Courson, L. Sedeno, K. Rogg, J.R. Orozco-Arroyave, E. Noth, S. Skodda, N. Trujillo, M. Rodriguez, J. Rusz, E. Munoz, J.F. Cardona, E. Herrera, E. Hesse, A. Ibanez, G. Cecchi, A.M. Garcia. (2020). “From discourse to pathology: Automatic identification of Parkinson’s disease patients via morphological measures across three languages,” Cortex, 132 (November): 191-205. [PDF]

J. Rusz, and T. Tykalová. (2020). “Reader response: Motor speech patterns in Huntington disease,” Neurology, 95 (13 September). [PDF]

R. Krupička, P. Krýže, S. Neťuková, T. Duspivová, O. Klempíř, Z. Szabó, P. Dušek, K. Šonka, J. Rusz, E. Růžička. Instrumental analysis of finger tapping reveals a novel early biomarker of parkinsonism in idiopathic rapid eye movement sleep behaviour disorder,” Sleep Medicine, 75 (November): 45-49. [PDF]

T. TykalováJ. RuszJ. Švihlík. S. Bancone, A. Spezia, and M. T. Pellecchia. (2020). “Speech disorder and vocal tremor in postural instability/gait difficulty and tremor dominant subtypes of Parkinson’s disease,” Journal of Neural Transmission, 127 (9 September): 1295-1304. [PDF]

D. Škrabal, T. Tykalová, J. Klempíř, E. Růžička, and J. Rusz. (2020). “Dysarthria enhancement mechanism under external clear speech instruction in Parkinson’s disease, progressive supranuclear palsy and multiple system atrophy,” Journal of Neural Transmission, 127 (6 June): 905-914. [PDF]

J. HlavničkaT. Tykalová, O. Ulmanová, P. Dušek, D. Horáková, J. Klempíř, and J. Rusz. (2020). “Characterizing vocal tremor in progressive neurological diseases via automated acoustic analyses,” Clinical Neurophysiology, 131(5 May): 1155-1165. [PDF] [Editorial]

J. Hanuška, P. Dušek, J. Rusz, O. Ulmanová, A. Burgetová, and E. Růžička. (2020). “Eye movement abnormalities are associated with brainstem atrophy in Wilson disease,” Neurological Sciences, 41(5 May): 1097-1103. [PDF]

V. Illner, P. Sovka, and J.Rusz. (2020). “Validation of freely-available pitch detection algorithms across various noise levels in assessing speech captured by smartphone in Parkinson’s disease,” Biomedical Signal Processing and Control, 58(April): 101831. [PDF]

J. Hanuška, J. Rusz, O. Bezdíček, P. Dušek, K. Šonka, and E. Růžička. (2020). “Comment on “pro-saccades predict cognitive decline in Parkinson’s disease: ICICLE-PD”,” Movement Disorders, 35(3 March):522. [PDF]

M. Novotný, P. Dušek, I. Daly, E. Růžička, J.Rusz. (2020).”Glottal Source Analysis of Voice Deficits in Newly Diagnosed Drug-naive Patients with Parkinson’s Disease: Correlation Between Acoustic Speech Characteristics and Non-Speech Motor Performance,” Biomedical Signal Processing and Control, 57(March): 101818. [PDF]

S. Vítečková, J. Rusz, R. Krupička, P. Dušek, and E. Růžička. (2020).”Instrumental Analysis of Gait Abnormalities in Idiopathic Rapid Eye Movement Sleep Behavior Disorder,” Movement Disorders, 35(1 January):193-195. [PDF]

K. RozenstoksM. Novotný, D. Horáková, and J. Rusz. (2020).”Automated assessment of oral diadochokinesis in multiple sclerosis using a neural network approach: effect of different syllable repetition paradigms,” IEEE Transactions on Neural Systems and Rehabilitation Engineering, 28(January): 32-41. [PDF]

2019

J. HlavničkaR. Čmejla, J. Klempíř, E. Růžička, and J. Rusz. (2019).”Acoustic tracking of pitch, modal and subharmonic vibrations of vocal folds in Parkinson’s disease and Parkinsonism,” IEEE Access7(December): 150339-150354. [PDF]

P. Dušek, V. Ibarburu Lorenzo y Losada, O. Bezdíček, I. Dall’Antonia, S. Dostálová, P. Kovalská, R. Krupička, J. Nepožitek, T. Nikolai, M. Novotný, P. Peřinová, J. Rusz, T. Serranová, T.Tykalová, O. Ulmanová, Z. Mecková, V. Ptáčník, J. Trnka, D. Zogala, E. Růžička, and K. Šonka. (2019).”Relations of non-motor symptoms and dopamine transporter binding in REM sleep behavior disorder,” Scientific Reports9(October): 15463. [PDF]

J. Hanuška, J. Rusz, O. Bezdíček, O. Ulmanová, C. Bonnet, P. Dušek, V. Ibarburu, T. Nikolai, T. Sieger, K. Šonka, and E. Růžička. (2019). “Eye Movements in Idiopathic REM Sleep Behavior Disorder: High Antisaccade Error Rate Reflects Prefrontal Cortex Dysfunction,” Journal of Sleep Research28(October): e12742. [PDF] [cited]

J. Rusz, M. Vaněčková, B. Beňová, T. TykalováM. Novotný, H. Růžičková, T. Uher, M. Andělová, K. Novotná, L. Friedová, J. Motýl, K. Kučerová, J. Krásenský, D. Horáková. (2019). “Brain volumetric correlates of dysarthria in multiple sclerosis,” Brain and Language194(7 July): 58-64. [PDF]

L. Friedová, J. Rusz, J. Motýl, B. Srpová, K. Vodehnalová, M. Andělová, K. Novotná, M. Novotný, H. Růžičková, T. Tykalová, E. Kubala Havrdová, D. Horáková, and T. Uher. (2019). “Slowed articulation rate is associated with information processing speed decline in multiple sclerosis: A pilot study,” Journal of Clinical Neuroscience65(7 July): 28-33. [PDF]

K. Novotná, J. Rusz, E. Kubala Havrdová, J. Lízrová Preiningerová. (2019). “Why patients with multiple sclerosis perceive improvement of gait during treatment with natalizumab?,” Journal of Neural Transmission126(6 June): 731-737. [PDF] [cited]

J. RuszT. Tykalová, G. Salerno, S. Bancone, J. Scarpelli, M. T. Pellecchia. (2019). “Distinctive speech signature in cerebellar and parkinsonian subtypes of multiple system atrophy,” Journal of Neurology266(6 June): 1394-1404. [PDF] [cited]

L. Brabcová, J. Roth, O. Ulmanová, J. Rusz, J. Klempíř, O. Horáček, M. Kolářová, P. Kosková, P. Rolková, H. Božková, L. Sabó, M. Inemanová, K. Lísalová, F. Jančok, E. Růžička, and H. Brožová. (2019).”Inpatient multidisciplinary rehabilitation program for postural and gait stability in Huntington´s disease – a pilot study,” Česká a slovenská neurologie a neurochirurgie82/115(5-6 May): 301-308. [PDF]

J. Rusz, A. Fečíková, T. Tykalová, R. Jech. (2019). “Effect of pallidal deep-brain stimulation on articulation rate in dystonia,” Neurological Sciences40(April): 869–873. [PDF]

L. Moro-Velazquez, J. A. Gomez-Garcia, J. I. Godino-Llorente, J. Villalba, J. Rusz, S. Shattuck-Hufnagel, N. Dehak. (2019). “A forced gaussians based methodology for the differential evaluation on Parkinson’s disease by means of speech processing,” Biomedical Signal Processing and Control (February), 48: 205-220. [PDF] [cited]

2018

J. RuszJ. HlavničkaT. TykalováM. Novotný, P. Dušek, K. Šonka, and E. Růžička. (2018). “Smartphone allows capture of speech abnormalities associated with high risk of developing Parkinson’s disease,” IEEE Transactions on Neural Systems and Rehabilitation Engineering26(8 August): 1495-1507. [PDF] [cited]

J. RuszT. Tykalová, A. Fečíková, D. Šťastná, D. Urgošík, R. Jech. (2018). “Dualistic effect of pallidal deep brain stimulation on motor speech disorders in dystonia,” Brain Stimulation11(4 July-August): 896-903. [PDF] [cited]

M. Skorvanek, E. Feketeova, M. M. Kurtis, J. Rusz, and K. Šonka. (2018). “Accuracy of rating scales and clinical measures for screening of rapid eye movement sleep behavior disorder and for predicting conversion to Parkinson’s disease and other synucleinopathies,” Frontiers in Neurology9(May): 376. [PDF] [cited]

J. Rusz, B. Beňová, H. Růžičková, M. NovotnýT. TykalováJ. Hlavnička, T. Uher, M. Vaněčková, M. Andělová, K. Novotná, L. Kadrnožková, and D. Horáková. (2018). “Characteristics of motor speech phenotypes in multiple sclerosis,” Multiple Sclerosis and Related Disorders19(1 January): 62-69. [PDF] [cited]

2017

J. RuszM. NovotnýJ. HlavničkaT. Tykalová, and E. Růžička. (2017). High-accuracy voice-based classification between patients with Parkinson’s disease and other neurological diseases may be an easy task with inappropriate experimental design. IEEE Transactions on Neural Systems and Rehabilitation Engineering25(8 August): 1319-1321. [PDF] [cited]

C. Bonnet, J. Rusz, J. Hanuška, M. Dezortová, F. Jírů, T. Sieger, R. Jech, J. Klempíř, J. Roth, O. Bezdíček, T. Serranová, P. Dušek, T. Uher, C. Flammand-Roze, M. Hájek, and E. Růžička (2017). GABA spectra and remote distractor effect in progressive supranuclear palsy: A pilot study. Revue Neurologique173(4 April): 225-229. [PDF] [cited]

J. RuszT. Tykalová, R. Krupička, K. Zárubová, M. Novotný, R. Jech, Z. Szabó, and E. Růžička. (2017). “Comparative analysis of speech impairment and upper limb motor dysfunction in Parkinson’s disease,” Journal of Neural Transmission124(4 April): 463-470. [PDF] [cited]

J. HlavničkaR. ČmejlaT. Tykalová, K. Šonka, E. Růžička, and J. Rusz (2017). “Automated analysis of connected speech reveals early biomarkers of Parkinson’s disease in patients with rapid eye movement sleep behaviour disorder,” Scientific Reports7(February): 12. [PDF] [cited]

T. TykalováJ. Rusz, J. Klempíř, R. Čmejla, and E. Růžička. (2017). “Distinct patterns of consonant articulation among Parkinson’s disease, progressive supranuclear palsy and multiple system atrophy,” Brain and Language165(2 February): 1-9. [PDF] [cited]

2016

M. NovotnýJ. RuszR. Čmejla, H. Růžičková, J. Klempíř, and E. Růžička. (2016). “Hypernasality associated with basal ganglia dysfunction: evidence from Parkinson’s disease and Huntington’s disease,” PeerJ4(September): 2530. [PDF] [suppl. material] [cited]

A.M. Rulseh, J. Keller, J. Rusz, M. Syka, H. Brožová, R. Rusina, P. Havránková, K. Zárubová, H. Malíková, R. Jech, and J. Vymazal. (2016). “Diffusion tensor imaging in the characterization of multiple system atrophy,” Neuropsychiatric Disease and Treatment12(August): 2181-2187. [PDF] [cited]

J. RuszT. Tykalová, J. Klempíř, R. Čmejla, and E. Růžička. (2016). “Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson’s disease: a longitudinal follow-up study on previously untreated patients,” Journal of Neural Transmission123(4 April): 379-387. [PDF] [cited]

J. RuszJ. HlavničkaT. Tykalová, J. Bušková, O. Ulmanová, E. Růžička and K. Šonka. (2016). “Quantitative assessment of motor speech abnormalities in idiopathic rapid eye movement sleep behaviour disorder,” Sleep Medicine19(3 March): 141-147. [PDF] [cited]

T. Tykalová, M. Pospíšilová, R. Čmejla, J. Jeřábek, P. Mareš, J. Rusz. (2016). “Speech changes after coordinative training in patients with cerebellar ataxia: A pilot study,” Neurological Sciences37(2 February): 293-296. [PDF] [cited]

J.R. Orozco-Arroyave, F. Honig, J.D. Arias-Londono, J.F. Vargas-Bonilla, K. Daqrouq, S. Skodda, J. Rusz, and E. Noth. (2016). “Automatic detection of Parkinson’s disease in running speech spoken in three different languages,” Journal of the Acoustical Society of America139(1 January): 481-500. [PDF] [cited]

2015

J.R. Orozco-Arroyave, E.A. Belalcazar-Bolanos, J.D. Arias-Londono, J.F. Vargas-Bonilla, S. Skodda, J. Rusz, K. Daqrouq, F. Honig, and E. Noth. (2015). “Characterization Methods for the Detection of Multiple Voice Disorders: Neurological, Functional, and Laryngeal Diseases,” IEEE Journal of Biomedical and Health Informatics19(6 November): 1820-1828. [PDF] [cited]

T. TykalováJ. RuszR. Čmejla, J. Klempíř, H. Růžičková, J. Roth, and E. Růžička. (2015). “Effect of dopaminergic medication on speech dysfluency in Parkinson’s disease: a longitudinal study,” Journal of Neural Transmission122(8 August): 1135-1142. [PDF] [cited]

J. RuszJ. HlavničkaR. Čmejla, and E. Růžička. (2015). “Automatic evaluation of speech rhythm instability and acceleration in dysarthrias associated with basal ganglia dysfunction,” Frontiers in Bioengineering and Biotechnology3(July):104. [PDF] [cited]

J. Hanuška, C. Bonnet, J. Rusz, T. Sieger, R. Jech, S. Rivaud-Péchoux, M. Vidailhet, B. Gaymard, and E. Růžička. (2015). “Fast Vergence Eye Movements Are Disrupted in Parkinson’s Disease: A Video-oculography Study” Parkinsonism & Related Disorders21(7 July): 797-799. [PDF] [cited]

J. Rusz, C. Bonnet, J. Klempíř, T. Tykalová, E. Baborová, M. Novotný, A. Rulseh, and E. Růžička. (2015). “Speech disorders reflect differing pathophysiology in Parkinson’s disease, progressive supranuclear palsy and multiple system atrophy,” Journal of Neurology262(4 April): 992-1001. [PDF] [cited]

J. Lízrová Preiningerová, K. Novotná, J. Rusz, L. Suchá, E. Růžička, and E. Havrdová. (2015). “Spatial and Temporal Characteristics of Gait as Outcome Measures in Multiple Sclerosis (EDSS 0 to 6.5),” Journal of NeuroEngineering and Rehabilitation12(February): 14. [PDF] [cited]

2014

J. Rusz, J. Klempíř, T. Tykalová, E. Baborová, R. Čmejla, E. Růžička, and J. Roth. (2014). “Characteristics and occurrence of speech impairment in Huntington’s disease: possible influence of antipsychotic medication,” Journal of Neural Transmission121(12 December): 655-664. [PDF] [cited]

J. Rusz, C. Saft, U. Schlegel, R. Hoffman, S. Skodda. (2014). “Phonatory Dysfunction as a Preclinical Symptom of Huntington Disease,” PLoS One9(11 November): e113412. [PDF] [cited]

M. NovotnýJ. RuszR. Čmejla, E. Růžička. (2014). Automatic evaluation of articulatory disorders in Parkinson’s disease. IEEE/ACM Transactions on Audio, Speech, and Language Processing22(9 September): 1366-1378. [PDF] [cited]

C. Bonnet, J. Rusz, M. Megrelishvili, T. Sieger, O. Matoušková, M. Okujava, H. Brožová, T. Nikolai, J. Hanuška, M. Kapianidze, N. Mikeladze, N. Botchorishvili, I. Khatiashvili, M. Janelidze, T. Serranová, O. Fiala, J. Roth, J. Bergquist, R. Jech, S. Rivaud-Péchoux, B. Gaymard, E. Růžička. (2014). “Eye Movements in Ephedrone-induced Parkinsonism,” PLoS One9(8 August): e104784. [PDF] [cited]

J. Rusz, M. Megrelishvili, C. Bonnet, M. Okujava, H. Brožová, I. Khatiashvili, M. Sekhniashvili, M. Janelidze, E. Tolosa, E. Růžička. (2014). “A distinct variant of mixed dysarthria reflects parkinsonism and dystonia due to ephedrone abuse,” Journal of Neural Transmission121(6 June): 655-664. [PDF] [suppl. material] [cited]

T. TykalováJ. RuszR. Čmejla, H. Růžičková, and E. Růžička. (2014). “Acoustic Investigation of Stress Patterns in Parkinson’s Disease,” Journal of Voice28(1 January): 129.e1-129.e8. [PDF] [cited]

2013 and older

C. Bonnet, J. Hanuška, J. Rusz, S. Rivaud-Péchoux, T. Sieger, V. Majerová, T. Serranová, B. Gaymard, and E. Růžička. (2013). “Horizontal and Vertical Eye Movement Metrics: What´s Important?” Clinical Neurophysiology124(11 Novemeber): 2216-2229. [PDF] [cited]

J. RuszR. ČmejlaT. Tykalová, H. Ružičková, Jiří Klempíř, Veronika Majerová, Jana Picmausová, Jan Roth, and E. Růžička. (2013). “Imprecise vowel articulation as a potential early marker of Parkinson’s disease: Effect of speaking task,” Journal of the Acoustical Society of America134(3 October): 2171-2181. [PDF] [cited]

J. Rusz, J. Klempíř, E. Baborová, T. Tykalová, V. Majerová, R. Čmejla, E. Růžička, and J. Roth. (2013). “Objective Acoustic Quantification of Phonatory Dysfunction in Huntington’s Disease,” PLoS One8(6 June): e65881. [PDF] [cited]

J. RuszR. Čmejla, H. Ružičková, J. Klempíř, V. Majerová, J. Picmausová, J. Roth, and E. Růžička. (2013). “Evaluation of speech impairment in early stages of Parkinson’s disease: a prospective study with the role of pharmacotherapy,” Journal of Neural Transmission120(2 February): 319-329. [PDF] [cited]

R. ČmejlaJ. RuszP. Bergl, and J. Vokřál. (2013). Bayesian changepoint detection for the automatic assessment of fluency and articulatory disorders. Speech Communication55(1 January): 178-189. [PDF] [suppl. material] [cited]

J. RuszR. Čmejla, H. Ružičková, J. Klempíř, V. Majerová, J. Picmausová, J. Roth, and E. Růžička. (2011). “Acoustic assessment of voice and speech disorders in Parkinson’s disease through quick vocal test,” Movement Disorders26(10): 1951-1952. [PDF] [suppl. material] [cited]

J. Kofránek, S. Matoušek, J. Rusz, P. Stodůlka, P. Privitzer, M. Mateják, and M. Tribula. (2011). “The Atlas of Physiology and Pathophysiology: Web-Based Multimedia Enabled Interactive Simulations,” Computer Methods and Programs in Biomedicine104(2): 143-153. [PDF] [www] [cited]

J. RuszR. Čmejla, H. Ružičková, and E. Růžička. (2011). “Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson’s disease,” Journal of the Acoustical Society of America129(1): 350-367. [PDF] [cited]